UNICHEMLAB.BO

Healthcare Drug Manufacturers - Specialty & Generic

Unichem Laboratories Limited

₹551.80

+4.80 +0.88% today

Price History

Not enough data

Key Stats

Market Cap

38.85B

Avg Volume

29,653

P/E (TTM)

12.77

EPS

₹43.22

52W High

₹685.95

52W Low

₹280.00

Div. Yield

0.0%

Valuation

Forward P/E

27.73

P/B Ratio

1.43

P/S Ratio

1.68

EV/EBITDA

17.59

EV/Revenue

1.76

PEG Ratio

4.00

Margins

Gross Margin 50.7%

Operating Margin 6.3%

Net Margin 13.2%

EBITDA Margin 10.0%

Growth & Returns

Revenue Growth (YoY)

20.1%

Liquidity & Leverage

Debt / Equity

0.18

Total Cash

2.89B

Total Debt

5.00B

About

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in Asia, Europe, Africa, CIS, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, formulations, bulk drugs, and chemicals. It serves distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited.